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For the last two decades, endoscopic polypectomy has been widely
used for the treatment of neoplastic lesions of the large intestine,
and this technique is now assumed to be satisfactory for the treat-
ment of colorectal adenomas. However, it is still controversial
whether endoscopic polypectomy is suitable once carcinomatous
cells penetrate the muscularis mucosae (Colacchio et al, 1981;
Cooper, 1983; Morson et al, 1984; Haggitt et al, 1985; Cranley 
et al, 1986; Christie, 1988; Muto et al, 1991). Lymph node metas-
tasis, residual carcinoma, local recurrence and hepatic involve-
ment have been reported to occur in about 6%, 6%, 4% and 1% of
cases of early invasive colorectal carcinomas removed by polypec-
tomy (Furusawa, 1985; Muto et al, 1991). To reduce the adverse
outcome of these cases, many researchers have advocated the
following histological criteria; massive submucosal invasion,
vascular invasion, or poorly differentiated histology, when consid-
ering additional surgery after endoscopic resection of early invasive
colorectal carcinomas (Morson et al, 1977; Colacchio et al, 1981;
Haggitt et al, 1985; Furusawa, 1985; Muto et al, 1991). However,
the positive predictive value of these histological features is
rather low, about 20%, and a more useful risk factor is needed in
the clinical setting. 
The proteolytic degradation of extracellular matrix by matrix
metalloproteinases (MMP) has been shown to be one of the essen-
tial events in tumour invasion and metastasis (Stetler-Stevenson,
1993; Crawford and Matrisian, 1995). Matrilysin (MMP-7) is a
member of the MMP gene family, and has proteolytic activity
against a wide spectrum of substrates such as collagens, proteo-
glycans, elastin, laminin, fibronectin and casein (Woessner and
Taplin, 1988; Miyazaki et al, 1990; Wilson and Matrisian, 1996).
It is produced by malignant tumour cells such as oesophageal,
gastric, colorectal, head and neck, lung, prostate and hepato-
cellular carcinomas (Yamamoto et al, 1997; Adachi et al, 1998;
Yamashita et al, 1998; Adachi et al, 1999; Babletz et al, 1999;
Yamamoto et al, 1999). Immunohistochemical studies have shown
that the expression of matrilysin correlates significantly with nodal
or distant metastasis in gastric and colorectal carcinomas (Adachi
et al, 1998–1999; Yamashita et al, 1998). In oesophageal squa-
mous cell carcinomas, matrilysin expression is associated with the
depth of tumour invasion, advanced tumour stage, recurrence, and
recurrence within the first postoperative year; however, no signifi-
cant association is seen between matrilysin expression and nodal
or distant metastasis (Yamamoto et al, 1999). These studies were
based on univariate analysis; therefore, no definite conclusion
could be obtained about the implication of matrilysin expression
with reference to clinicopathologic parameters. Furthermore, no
previous studies were performed focusing on early invasive color-
ectal carcinomas. This study was undertaken to clarify the associa-
tion of matrilysin expression with clinicopathologic characteristics
of early invasive colorectal carcinomas using univariate and
multivariate analysis. 
PATIENTS AND METHODS 
Patients 
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ined retrospectively. 11 patients underwent local excision initially
(endoscopic mucosal resection, 5; transanal resection, 4; trans-
sacral resection, 2), and additional bowel resection with lymph
node dissection was attempted in 6 patients after histological
examination of the resected specimens. The remaining 27 patients
underwent radical surgery (bowel resection with lymph node
dissection) initially. 27 were men and 11 were women. The mean
age was 66 years with a range of 40 to 85 years. The depth of inva-
sion was submucosal in all tumours. The tumour location was the
rectum in 14, the left colon in 12, and the right colon in 12
patients. Patients’ clinical records and pathological reports were
reviewed with special attention to the presence or absence of
lymph node metastases, local recurrence and distant metastases. 
Tissues 
From each resected specimen, one archival formalin-fixed
paraffin-embedded tissue block containing normal mucosa was
selected for immunohistochemical study. 5-mm-thick paraffin
sections were cut from each block, and mounted on lysin-coated
slides. 
Immunohistochemistry 
Immunostaining for matrilysin was performed using a standard
avidin-biotin peroxidase technique. Sections were deparaffinized
in xylene, and hydrolysed with 100%, 90%, 80% and 70% ethanol.
The antibody used was anti-hMMP-7 mouse monoclonal antibody
(clone 141-7B2; Fuji Chemical, Toyama, Japan). This antibody is
specific for human pro-MMP-7, and does not cross-react with
human active-MMP-7, MMP-1, -2, -3, -8, -9 or -13. As the antigen
retrieval procedure for matrilysin, the sections were heated to
121˚C in an autoclave for 15 min. Endogenous peroxidase was
blocked with 0.3% H2O2 in PBS (30 min), and the sections were
rinsed in PBS. Non-specific staining was eliminated by 30 min of
incubation with normal horse serum. The sections were incubated
at 4˚C overnight with primary antibody (1:50, 10 mgm l –1), at 37˚C
with biotinylated secondary antibodies for 30 min, and with
avidin-biotin complex for 30 min. Peroxidase reaction was visual-
ized with a solution of DAB (diaminobenzidine tetrahydrochlo-
ride). The sections were counterstained with haematoxylin,
dehydrated and mounted. 
Evaluation of matrilysin expression 
Immunostaining signals at the invasive margin were counted, and
the scores were calculated as the number of stained cells divided
by the total number of carcinoma cells at the invasive margin.
Cases were considered positive when >30% of carcinoma cells at
the invasive margin were stained with the antibody, according to a
previous report (Yamamoto et al, 1999). 
Evaluation of clinicopathological parameters 
A consecutive section from each specimen was stained with
haematoxylin and eosin. Tumours were evaluated for predominant
grade, lymphatic vessel invasion, blood vessel invasion, regional
lymph node involvement, surgical margin status, presence or
absence of adenomatous component, and presence or absence of
dedifferentiated histology at the invasive margin, the finding of a
single cancer cell or a solitary trabecular form along the entire
invasive margin, which was identical to ‘budding’ (Hase et al,
1993) (Figure 1). For objective evaluation, the number of dediffe-
rentiation units along the entire invasive margin was counted
under light microscopy, and graded into 4 categories; none (0
unit), mild (1~20 units), moderate (21~50 units) and severe (^ 51
units) according to a previous publication (Ono et al, 1996). The
depth of submucosal invasion was graded into 3 levels, as
described previously (Masaki and Muto, 2000). 
Statistical analysis 
The associations between matrilysin expression and clinicopatho-
logic parameters were examined using c2 (chi-squared) test or
Fisher’s exact test. The associations between adverse outcome and
clinicopathologic parameters including matrilysin expression were
analysed using multiple logistic regression analysis (software,
SPSS for Macintosh, version 6.1 (Chicago, IL, USA)). A P value
less than 0.05 was accepted as statistically significant. 
RESULTS 
Demographic features of 7 patients with adverse
outcome 
As shown in Table 1, lymph node metastases were found in the
radically resected specimens in 3 patients, and distant metastases
in 3 patients. One patient had local recurrence, although he had
undergone ‘potentially curative’ trans-anal resection for a 20-mm
rectal tumour one year before. This recurrence was assumed to be
due to residual lymphatic vessel involvement. 
Matrilysin expression 
Figure 2 shows representative results of matrilysin staining in
early invasive colorectal carcinomas. The cytoplasm and cell
membrane of carcinoma cells were stained for matrilysin, but
stromal cells other than some monocytes or surrounding normal
mucosa were not stained. In this study, matrilysin expression was
positive in 13 of 38 tumours (34%) examined (Table 2). 
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Figure 1 Representative photograph of tumour budding at the invasive
margin. Small nests of cancer cells with poorly differentiated histology at the
invasive margin of the tumour (arrows). H&E, ´50 Matrilysin and early invasive colorectal carcinoma 1319
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Table 1 Demographic details of 7 patients with adverse outcome 
Sex Age Location Size  Shape Treatment Histology sm–inv ly v adenoma LN met Local rec Distant met
(mm) 
M 47 Rectum 20 S LE W 1 – – – – + – 
M 75 Rt. Colon 8 P LE+RS M 2 + – – + – –
M 71 Rectum 17 U RS P 3 – – + + – – 
F 74 Lt. Colon 40 P RS W 1 – – + + – – 
M 73 Rectum 30 P RS W 1 – – – – – Liver (8 m) 
M 61 Rectum 15 S LE W 3 – + – – – Bone, lung (2 y) 
M 73 Rt. Colon 12 S RS W 3 – – – – – Lung (4 y) 
M, male; F, female; P, pedunculated; S, sessile; U, ulcerated; LE, local excision; RS, radical surgery; W, well differentiated; P, poorly differentiated; sm-inv, level
of submucosal invasion; ly, lymphatic invasion; v, venous invasion; adenoma, presence/absence of adenomatous component; LN, lymph node; met, metastasis;
rec, recurrence. 
Figure 2 Representative photographs of matrilysin expression in early invasive colorectal carcinomas. (A) Matrilysin is strongly positive at the invasive margin,
´50. (B) Matrilysin is negative in a rectal submucosal carcinoma, ´50
Table 2 Association of matrilysin expression with clinicopathologic parameters 
Matrilysin expression 
Variables Category Positive Negative P
Histological differentiation Well 12 20 
Moderate 1 3 NS 
Poor 0 2
Ly Negative 12 21 
Positive 1 4 NS 
V Negative 11 19 
Positive 2 6 NS 
Depth of invasion sm1 4 8 
sm2 1 4 NS 
sm3 8 13 
Tumour budding None 2 10 
Mild 9 8 
Moderate 1 5 NS 
Severe 1 2 
Distant metastasis Negative 10 25 
Positive 3 0 0.0339 
Adverse outcome Negative 8 23 
Positive 5 2 0.0341 
NS, not significant; Ly, lymphatic invasion; V, venous invasion. Matrilysin expression and clinicopathologic parameters 
As shown in Table 2, matrilysin expression was positive in 5 of 7
tumours (71%) with an adverse outcome, and in 8 of 31 tumours
(26%) without an adverse outcome. This difference was statisti-
cally significant (P = 0.0341, Fisher’s exact test). Matrilysin
expression was positive in all 3 tumours (100%) with distant
metastasis, and in 10 of 35 tumours (29%) without distant metas-
tasis. This difference was also statistically significant (P = 0.0339,
Fisher’s exact test). Matrilysin expression was not significantly
associated with histological differentiation, vessel invasion, depth
of invasion and grade of tumour budding. 
Adverse outcome and clinicopathologic parameters 
Univariate analysis showed that matrilysin expression alone was
significantly associated with distant metastasis (P = 0.0339,
Fisher’s exact test), and both tumour budding and matrilysin
expression were significantly associated with adverse outcome
(P= 0.0005, 0.0341; Table 3). Histological differentiation, vessel
invasion, and depth of invasion were not significantly associated
with either distant metastasis or adverse outcome. Multivariate
logistic regression analysis using tumour budding and matrilysin
expression as independent variables confirmed that both factors
were independently associated with adverse outcome, although the
significance of matrilysin expression was marginal (Table 4). 
DISCUSSION 
Tumour budding is a histological finding that tumour cells are
dissociating from the main tumour. Hase et al and Ono et al have
recently reported that the presence of microscopic clusters of
undifferentiated cancer cells at the invasive front of the lesion is
one of the most useful factors for identifying groups at high risk
of haematogeneous or regional metastasis among patients with
advanced colorectal cancer (Hase et al, 1993; Ono et al, 1996). In
an earlier study, we demonstrated that tumour budding was more
useful in predicting lymph node metastasis in early invasive color-
ectal carcinomas than the following histological criteria; massive
submucosal invasion, vascular invasion or poorly differentiated
histology (Masaki and Muto, 2000). In this study, we showed that
tumour budding was significantly associated with adverse
outcome, i.e. lymph node metastasis, local recurrence or distant
metastasis in early invasive colorectal carcinomas, suggesting that
tumour budding could represent malignant potential of early inva-
sive colorectal carcinomas in a broader sense. In this study, tumour
budding was evaluated objectively by counting the number of
focally dedifferentiated cancer cell nests or a single cancer cell at
the invasive margin, and graded into none, mild, moderate and
severe according to Ono et al’s publication (Ono et al, 1996).
Although the association of tumour budding with adverse outcome
was statistically significant in this study, the frequency of adverse
outcome was not completely parallel with the grade of tumour
budding. As shown in Table 3, none of 6 tumours (0%) with
moderate budding had an adverse outcome; however, 4 of 17
tumours (23%) with mild budding had an adverse outcome,
suggesting that the number of focally dedifferentiated cancer cell
nests or a single cancer cell alone does not satisfactorily imply
tumour aggressiveness. 
Matrilysin (MMP-7) is a member of the matrix metalloprotein-
ases (MMP) and has a proteolytic activity against a wide spectrum
of extracellular matrix (Woessner et al, 1988; Miyazaki et al, 1990;
1320 T Masaki et al 
British Journal of Cancer (2001) 84(10), 1317–1321 © 2001 Cancer Research Campaign
Table 3 Patients’ outcome and clinicopathologic parameters 
Distant metastasis Adverse outcome 
Variables Category Present Absent P Present Absent P
Histological differentiation Well 3 29 5 27
Moderate 0 4 NS 1 3 NS 
Poor 0 2 1 1 
Ly Negative 3 30 6 27
Positive 0 5 NS 1 4 NS 
V Negative 2 28 6 24 
Positive 1 7 NS 1 7 NS 
Depth of invasion sm1 1 11 3 9 
sm2 0 5 NS 1 4 NS 
sm3 2 19 3 18 
Tumour budding None 0 12 0 12 
Mild 2 15 4 13 
Moderate 0 6 NS 0 6 0.0005 
Severe 1 2 3 0 
Adenomatous component Negative 0 8 2 6 
Positive 3 27 NS 5 25 NS 
Matrilysin expression Negative 0 25 2 23 
Positive 3 10 0.0339 5 8 0.0341 
NS, not significant; Ly, lymphatic invasion; V, venous invasion. Adverse outcome includes lymph node metastasis, local recurrence
and distant metastasis. 
Table 4 Multivariate analysis 
Variable Odds ratio P value 
Tumour budding 13.8 0.0338 
Matrilysin expression 51.6 0.0488 
Model chi-squared 16.013, df 2, P = 0.0003.Wilson et al, 1996). Previous immunohistochemical studies have
shown that matrilysin expression correlates significantly with
nodal or distant metastasis in gastric and colorectal carcinomas
(Adachi et al, 1998, 1999; Yamashita et al, 1998). However, these
studies mainly examined advanced carcinomas, and the associa-
tion of matrilysin expression with clinicopathologic parameters
was studied using univariate analysis alone. In this multivariate
logistic regression analysis, matrilysin expression was signifi-
cantly and independently associated with distant metastasis or
adverse outcome in early invasive colorectal carcinomas, con-
firming that matrilysin expression plays a crucial role in tumour
invasion and metastasis at its earliest stage. 
These immunohistochemical results can be applicable in clin-
ical practice. Radical surgery with lymph node dissection or adju-
vant chemotherapy should be given in about 10–15% of patients
with early invasive colorectal carcinomas removed by polypec-
tomy (Furusawa, 1985; Muto et al, 1991). Although histological
criteria such as massive submucosal invasion, vascular invasion,
or poorly differentiated histology have been widely accepted as
risk factors in considering additional radical surgery (Morson et al,
1977; Colacchio et al, 1981; Furusawa, 1985; Haggitt et al, 1985;
Muto et al, 1991), the positive predictive value of these factors was
rather low, about 20%, and more useful risk factors have been
looked for. The present study and our previous study (Masaki et al,
2000) suggested that tumour budding at the invasive margin and
matrilysin expression are more useful in identifying high-risk
groups for adverse outcome in patients with early invasive
colorectal carcinomas. 
A large prospective study is mandatory to confirm the useful-
ness of tumour budding and matrilysin expression in the manage-
ment of early invasive colorectal carcinomas. 
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